.AstraZeneca has actually shared a very early look at the performance of its own in-house antibody-d...
.After declaring a stage 3 launch based upon positive midstage end results, iTeos and GSK are actual...
.The FDA must be actually even more available and also joint to release a rise in commendations of u...
.It's an unusually active Friday for biotech IPOs, along with Zenas BioPharma, MBX as well as Bicara...
.Atea Pharmaceuticals' antiviral has actually failed an additional COVID-19 test, however the biotec...
.Neurocrine Biosciences' mental illness program pivot has neglected. The biotech was incapable to im...
.Sanofi has actually brought in a late entry to the radioligand gathering, paying one hundred thousa...
.After F2G's 1st attempt to acquire a new training class of antifungal to market was actually hinder...
.Moderna has actually pledged to cut R&D costs through $1.1 billion by 2027. The choice to retrac...
.Only four months after Sanofi bet $80 million in beforehand money on Fulcrum Therapeutics' losmapim...